Please provide your email address to receive an email when new articles are posted on . Change in HbA1c and hypoglycemia rates were similar between once-weekly basal insulin and once-daily insulin ...
According to CRL, more information regarding the manufacturing process and the type 1 diabetes indication is needed before the review can be completed. The Food and Drug Administration (FDA) has ...
Please provide your email address to receive an email when new articles are posted on . Of 20 hospitals providing insulin algorithms, 60% stated which patients should initiate basal or nutritional ...
COMBINE 3 phase 3a trial successfully completed with once-weekly IcoSema demonstrating non-inferior reduction in HbA1c versus daily basal-bolus treatment (insulin glargine U100 and insulin aspart) in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback